Single-cell omics: a new perspective for early detection of pancreatic cancer?

Wang, Qi; Sabanovic, Berina; Awada, Ahmad; Reina, Chiara; Aicher, Alexandra; Tang, Jiajia; Heeschen, Christopher

doi:10.1016/j.ejca.2023.112940

Cited by 5 publications

References 173 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Current biological implications and clinical relevance of metastatic circulating tumor cells

Shahhosseini,

Pakmehr,

Elhami

et al. 2024

Clin Exp Med

View full text Add to dashboard Cite

Metastatic disease and cancer recurrence are the primary causes of cancer-related deaths. Circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) are the driving forces behind the spread of cancer cells. The emergence and development of liquid biopsy using rare CTCs as a minimally invasive strategy for early-stage tumor detection and improved tumor management is a promising advancement in recent years. However, before blood sample analysis and clinical translation, precise isolation of CTCs from patients’ blood based on their biophysical properties, followed by molecular identification of CTCs using single-cell multi-omics technologies is necessary to understand tumor heterogeneity and provide effective diagnosis and monitoring of cancer progression. Additionally, understanding the origin, morphological variation, and interaction between CTCs and the primary and metastatic tumor niche, as well as and regulatory immune cells, will offer new insights into the development of CTC-based advanced tumor targeting in the future clinical trials. Graphical Abstract

show abstract